Galdu-irabazien kontua
SONOMA PHARMACEUTICALS, INC.
SNOA
Errendimenduaren laburpena
Egin klik taulako edozein lerrotan grafikoan gehitzeko
milioika USDtan
| Neurria | Mar 31, 2025 2024 FY | Mar 31, 2024 2023 FY | Mar 31, 2023 2022 FY | Mar 31, 2022 2021 FY | Mar 31, 2021 2020 FY | Mar 31, 2020 2019 FY | Mar 31, 2019 2018 FY | Mar 31, 2018 2017 FY | Mar 31, 2017 2016 FY | Mar 31, 2016 2015 FY | Mar 31, 2015 2014 FY | Mar 31, 2014 2013 FY | Mar 31, 2013 2012 FY | Mar 31, 2012 2011 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Diru-sarrerak
|
14.29 | 12.74 | 13.27 | 12.63 | 18.63 | 18.94 | 18.97 | 16.66 | 12.83 | 15.08 | 13.85 | 13.67 | 15.45 | 12.74 |
|
Diru-sarreren kostua
|
8.82 | 7.99 | 8.80 | 8.64 | 12.07 | 10.60 | 10.09 | 9.35 | 7.16 | 7.87 | 6.57 | 5.27 | 4.71 | 4.03 |
|
Irabazi gordina
|
5.47 | 4.75 | 4.48 | 3.99 | 6.56 | 8.33 | 8.88 | 7.31 | 5.67 | 7.21 | 7.29 | 8.40 | 10.74 | 8.71 |
|
Ustiapen-gastuak
|
9.18 | 9.45 | 9.05 | 9.88 | 10.01 | 15.00 | 20.14 | 21.50 | 18.64 | 17.36 | 13.95 | 14.45 | 14.12 | 15.18 |
|
Ikerketa eta garapena
|
1.81 | 1.87 | 0.21 | 0.13 | 0.56 | 1.34 | 1.52 | 1.58 | 1.58 | 1.81 | 1.53 | 2.89 | 2.22 | 1.98 |
|
Salmentak, orokorrak eta administratiboak
|
7.36 | 7.58 | 8.84 | 9.76 | 9.45 | 13.67 | 18.62 | 19.92 | 17.07 | 15.56 | 12.41 | 11.56 | 11.89 | 13.20 |
|
Beste ustiapen-gastu batzuk
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Ustiapen-irabaziak
|
-3.71 | -4.70 | -4.57 | -5.89 | -3.45 | -6.67 | -11.26 | -14.19 | -12.97 | -10.15 | -6.66 | -6.05 | -3.37 | -6.47 |
|
Ez-ustiapeneko diru-sarrerak
|
-0.80 | 0.33 | 0.61 | -0.47 | 0.45 | -3.85 | 0.08 | 0.14 | -0.04 | - | - | - | - | - |
|
Interesen diru-sarrerak
|
- | - | - | - | 0.02 | 0.05 | 0.19 | 0.26 | 0.02 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 |
|
Interesen gastuak
|
- | - | - | - | 0.01 | 0.02 | 0.03 | 0.04 | 0.00 | 0.00 | 0.00 | 1.06 | 1.11 | 0.93 |
|
Beste ez-ustiapeneko diru-sarrerak/gastuak
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Zerga aurreko irabazia
|
-2.91 | -5.03 | -5.18 | -5.42 | -1.47 | -0.23 | -1.25 | -14.33 | -12.94 | - | - | - | - | - |
|
Zerga-gastua
|
0.55 | -0.20 | -0.03 | -0.33 | 0.71 | 0.12 | 0.46 | 0.00 | -22.21 | - | - | - | - | - |
|
Partaidetza ez-kontrolatzailea
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Irabazi garbia
|
-3.46 | -4.84 | -5.15 | -5.09 | 3.29 | 4.60 | -11.80 | -14.33 | 9.27 | -10.16 | -8.20 | 3.74 | -5.43 | -7.33 |
Informazio osagarria
Akzioko datuak, eratorritakoak eta bestelakoak — ez dira galdu-irabazien kontuaren parte
milioika USDtan, bestela adierazi ezean
| Neurria | Mar 31, 2025 2024 FY | Mar 31, 2024 2023 FY | Mar 31, 2023 2022 FY | Mar 31, 2022 2021 FY | Mar 31, 2021 2020 FY | Mar 31, 2020 2019 FY | Mar 31, 2019 2018 FY | Mar 31, 2018 2017 FY | Mar 31, 2017 2016 FY | Mar 31, 2016 2015 FY | Mar 31, 2015 2014 FY | Mar 31, 2014 2013 FY | Mar 31, 2013 2012 FY | Mar 31, 2012 2011 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Amortizazioa eta balio-galera
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
-3.71 | -4.53 | -4.45 | -5.70 | -3.22 | -6.36 | -10.81 | -13.70 | -12.73 | -9.91 | -6.41 | -5.77 | -3.11 | -6.14 |
|
Akzioko irabazia (oinarrizkoa)
|
-2.79 | -0.53 | - | - | - | - | - | - | - | - | -0.85 | 0.54 | - | - |
|
EPS diluitua
|
-2.79 | -0.53 | - | - | - | - | - | - | - | - | -0.85 | 0.54 | - | - |
|
Akzioen batez besteko haztatua
|
1.24 | 9.09 | - | - | - | - | - | - | - | - | 9.66 | 6.88 | - | - |
|
Akzioen batez besteko haztatu diluitua
|
1.24 | 9.09 | - | - | - | - | - | - | - | - | 9.66 | 6.90 | - | - |
|
Irabazi globala
|
- | - | - | - | - | - | - | - | - | - | -8.64 | 3.66 | -5.37 | -7.48 |